Startups
Epithelix Sàrl is a Swiss biotech company specialized in human tissue engineering.
Epithelix provides innovative R&D solutions for the study of human respiratory diseases (e.g. Asthma, COPD, Cystic Fibrosis, etc.) and for inhalation toxicity testing of chemicals, while reducing the number of animal experiments.
Epithelix provides innovative R&D solutions for the study of human respiratory diseases (e.g. Asthma, COPD, Cystic Fibrosis, etc.) and for inhalation toxicity testing of chemicals, while reducing the number of animal experiments.
Overview
Location
Switzerland, Geneva, Plan-les-Ouates
Employees
11-50
Founded date
2006
FAQ about Epithelix
When was Epithelix founded?
Epithelix was founded in 2006.
Is Epithelix still active?
Yes, Epithelix is active; its latest activity on Parsers VC dates from Oct 9, 2026.